A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy. [electronic resource]
Producer: 20061025Description: 333-8 p. digitalISSN:- 0169-5002
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Deoxycytidine -- administration & dosage
- Disease-Free Survival
- Drug Administration Schedule
- Erlotinib Hydrochloride
- Fatigue -- chemically induced
- Female
- Gefitinib
- Hematologic Diseases -- chemically induced
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Quinazolines -- administration & dosage
- Salvage Therapy
- Survival Rate
- Tegafur -- administration & dosage
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.